Answers are grounded in this paper and cite their sources.
Background Mobile health (mHealth) apps for menstrual cycle and fertility tracking are widely used to support self-monitoring, reproductive planning, and health awareness among women. These tools also promise personalized predictions and convenient access to reproductive health information. Still, concerns persist regarding their clinical accuracy, adaptability to irregular cycles, algorithmic transparency, and real-world user experience. Objective This structured review aimed to evaluate the features, physiological integration, predictive performance, validation practices, and user-reported outcomes of mobile apps designed for menstrual and fertility tracking, and to contextualize the current evidence using the COSMIN (Consensus-based Standards for the Selection of Health Measurement Instruments) and ISPOR (International Society for Health Economics and Outcomes Research) evaluation frameworks. Methods A structured narrative review of studies evaluating mobile apps for menstrual cycle and fertility tracking was conducted. Literature published between January 2013 and October 2025 was identified through searches of PubMed, Embase, Scopus, and Web of Science, supplemented by semantic and citation-based searches in Semantic Scholar, OpenAlex, and Google Scholar. AI-assisted prioritization was used only to support screening efficiency, whereas human reviewers performed all eligibility decisions and data verification. Forty studies met the predefined eligibility criteria and were included in the qualitative synthesis. Because of substantial heterogeneity in study designs, outcomes, and validation methods, no meta-analysis was performed. Results Of the 40 included studies, most were observational and relied on self-reported data from a predominantly high-income, technologically literate population. Twenty-four apps incorporated physiological inputs, such as basal body temperature, luteinizing hormone measurements, or wearable-derived metrics, whereas others relied primarily on calendar-based predictions. Multiparameter and sensor-augmented approaches generally demonstrated higher agreement with biological or clinical reference standards than calendar-only methods, with selected studies reporting fertile-window prediction accuracies approaching 85% to 90% under optimal adherence conditions. However, only a small subset of apps has reported formal clinical validation or regulatory clearance. User satisfaction was strongly associated with perceived accuracy, personalization, and usability, whereas inaccurate predictions, particularly among users with irregular cycles, were linked to frustration, anxiety, and high attrition. Conclusions Menstrual and fertility tracking apps that integrate physiological signals outperform calendar-based approaches in terms of predictive performance; however, robust clinical validation, transparency, and inclusivity remain limited. Reported accuracy metrics should be interpreted cautiously because real-world adherence, irregular cycle patterns, and algorithmic bias substantially affect reliability. These tools are best positioned as decision-support and self-awareness technologies, rather than as autonomous diagnostic instruments. Future evaluations should apply standardized frameworks, such as COSMIN and ISPOR, explicitly communicate uncertainty, and prioritize diverse and irregular-cycle populations to ensure equitable and clinically meaningful digital reproductive health solutions.
No takes yet. Share an insight, caveat, or question.
Cedro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: